Drug therapy in paediatric patients [3]

Lancet

Volumn 357, Issue 9257, 2001, Pages 719-

  Groll, Andreas H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

CHILD; CHILDHOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; HUMAN; HUMAN RIGHTS; INFANT; LETTER; MAJOR CLINICAL STUDY; MYOCLONUS EPILEPSY; NETHERLANDS; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0035799123     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)71476-8     Document Type: Letter

References (5)

1. How to best serve children
2. Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial
3. Unapproved and off-label use of drugs in a children's hospital
4. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients
5. Immediate action needed to improve labeling of prescription drugs for pediatric patients